Trump Announces Deal to Lower Weight Loss Drug Prices for Americans

Major Announcement on Weight Loss Drug Pricing

• 📢 President Donald Trump announced a significant deal aimed at lowering the prices of popular weight loss drugs.
• 🤝 The agreement is with two of the world's largest pharmaceutical manufacturers: Eli Lilly and Novo Nordisk.
• 📉 The goal is to bring drug prices down to more accessible levels, with potential cuts of 200% to 700%.

Discounted Prices and Drug Availability

• 💊 The deal covers widely used GLP-1 weight loss drugs such as Wegovy, Ozempic, and Zepbound.
• 💰 Most people will pay between $245 to $350 per month for these medications.
• 💲 If the FDA approves an oral pill form, the price could be as low as $149 per month.
• 🌐 A new federal government website, Trump RX, will launch in January for direct consumer purchases at discounted rates.

Impact on Different Insurance Plans

• 🏥 For individuals on Medicare or Medicaid, the cost will be approximately $245 per month.
• 💳 Medicare co-pays are expected to be around $50 per month.
• ⚖️ These prices are significantly lower than the current cost, which can exceed $1,000 per month.

Broader Health Implications

• ❤️ The drugs, while primarily for weight loss, also show benefits for heart disease, diabetes, and other conditions.
• 🎯 Officials emphasize the goal of improving overall American health, not just facilitating weight loss.
• 📊 With approximately 40% of Americans affected by obesity, these drugs could address a major public health issue and a leading cause of preventable deaths.